Medical Patent News Published: Wednesday, 10-May-2006 Neuren Pharmaceuticals has announced that its patent application entitled “GPE Analogs and Peptidomimetics” (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.
Continue reading...Monday, October 2, 2006
Thursday May 11, 8:30 am ET VANCOUVER, BRITISH COLUMBIA–(CCNMatthews – May 11, 2006) – Allon Therapeutics Inc. (TSX:NPC – News), The Neuro Protection Company(TM), reported today in its first quarter 2006 operating results that it continued to achieve important milestones in its drug development programs.
Continue reading...Friday, September 29, 2006
Wednesday May 10, 8:03 am ET TORONTO, May 10 /CNW/ – NeuroMedix Inc. (”NeuroMedix”) (TSXV: NMX) today announced that its lead drug candidate for the treatment of Alzheimer’s disease, Minozac, is also effective in reducing brain inflammation in mice suffering traumatic brain injury (”TBI”) and in preventing the cognitive deficit that generally results from such injury.
Continue reading...Wednesday, September 27, 2006
Published April 21, 2006 CHICAGO — Seven months after she was critically injured in a train derailment on Metra’s Rock Island District Line, Renea Poppel returned home for the first time Thursday, officials said.
Continue reading...Monday, September 25, 2006
Substance Abuse GREENLAND – Celebrate Recovery: A Christ-centered 12-Step Recovery Program based on the scripture and open to the public, will be held from 6:30 to 8:30 p.m. Thursday evenings at Bethany Church, 500 Breakfast Hill Road, Greenland. For information, e-mail cr@bethanychurch.com, or come to a meeting.
Continue reading...
Monday, October 2, 2006
0 Comments